“Whoa! It’s like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Try 2 weeks free now

Medicinal Chemistry and Chemical Biology of New Generation Taxane Antitumor Agents

P‐glycoprotein (P‐GP)‐based multidrug resistance (MDR) and undesirable side effects are significant drawbacks to the clinical use of paclitaxel and docetaxel. Extensive SAR studies of taxanes in these laboratories led to the discovery of new generation taxanes that are highly active against not only drug‐sensitive but also drug‐resistant human cancer cell lines as well as tumor xenografts in mice. One of these second generation taxanes, SB‐T‐110131 (IDN5109), exhibited excellent pharmacological profile in the preclinical studies and has been selected for clinical development (re‐coded as Bay 59‐8862), which is currently in the phase II clinical trials. Bay 59‐8862 is orally active with high bioavailability, showing excellent activity against a variety of drug‐resistant tumors. “Advanced second generation taxanes” show essentially no difference in cytotoxicity against drug‐resistant and drug‐sensitive cell lines, virtually overcoming MDR. Photoaffinity labeling of P‐GP using photoreactive radiolabeled paclitaxel analogs has disclosed the paclitaxel‐binding domain of P‐GP. Highly efficient taxane‐based MDR reversal agents (TRAs) have also been developed, which can recover the cytotoxicity of paclitaxel to practically the original level against paclitaxel‐resistant MDR expressing cancer cells. Highly promising results have emerged from the study of taxane‐monoclonal antibody (MAb) immunoconjugates, which have been proved to specifically deliver extremely cytotoxic agents to tumor in an animal model. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png IUBMB Life Wiley
Loading next page...

You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy unlimited access and
personalized recommendations from
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $40/month

Try 2 weeks free now

Explore the DeepDyve Library

How DeepDyve Works

Spend time researching, not time worrying you’re buying articles that might not be useful.

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.

All the latest content is available, no embargo periods.

See the journals in your area

Simple and Affordable Pricing

14-day free trial. Cancel anytime, with a 30-day money-back guarantee.

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Best Deal — 25% off

Annual Plan

  • All the features of the Professional Plan, but for 25% off!
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

billed annually